Updates in therapeutics for folliculitis decalvans: A systematic review with evidence-based analysis.
Rambhia PH, Conic RRZ, Murad A, Atanaskova-Mesinkovska N, Piliang M, Bergfeld W.
J Am Acad Dermatol. 2019 Mar;80(3):794-801.e1. doi: 10.1016/j.jaad.2018.07.050. Epub 2018 Aug 6.
Folliculitis Decalvans.
Zhou L, Lin J, Wu W.
JAMA Dermatol. 2025 May 1;161(5):544-545. doi: 10.1001/jamadermatol.2025.0050.
Successful Management of Folliculitis Decalvans.
Kashikar Y, Saoji V, Madke B, Chandak MS, Meghe S.
Cureus. 2024 Jan 24;16(1):e52881. doi: 10.7759/cureus.52881. eCollection 2024 Jan.
Folliculitis decalvans.
Otberg N, Kang H, Alzolibani AA, Shapiro J.
Dermatol Ther. 2008 Jul-Aug;21(4):238-44. doi: 10.1111/j.1529-8019.2008.00204.x.
Recalcitrant Folliculitis Decalvans Treatment Outcomes With Biologics and Small Molecule Inhibitors.
Fakhoury T, Urban K, Ettefagh L, Nami N.
Cutis. 2024 May;113(5):E32-E34. doi: 10.12788/cutis.1023.
EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines.
Nowaczyk J, Fret K, Kaminska-Winciorek G, Rudnicka L, Czuwara J.
Anticancer Drugs. 2023 Sep 1;34(8):942-948. doi: 10.1097/CAD.0000000000001494. Epub 2023 Jan 24.
Chronic Lichenoid Folliculitis Decalvans.
López Mateos A, Plata Clemente S, Guerrero Ramírez C, Azaña Defez JM.
Actas Dermosifiliogr. 2022 Nov-Dec;113(10):968-969. doi: 10.1016/j.ad.2021.07.020. Epub 2022 Apr 22.
Folliculitis decalvans.
Brooke RC, Griffiths CE.
Clin Exp Dermatol. 2001 Jan;26(1):120-2. doi: 10.1046/j.1365-2230.2001.00746.x.
Scarring Alopecia.
Larrondo J, McMichael AJ.
Dermatol Clin. 2023 Jul;41(3):519-537. doi: 10.1016/j.det.2023.02.007. Epub 2023 Apr 14.
Folliculitis decalvans and dystrophic epidermolysis bullosa: a significant association.
Matard B, Bourrat E, Cavalié M, Chiaverini C, Reygagne P.
Br J Dermatol. 2022 Dec;187(6):1026-1028. doi: 10.1111/bjd.21796. Epub 2022 Sep 6.
